Cannabis Act

EQS-News: Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market

Retrieved on:

Wednesday, April 10, 2024

Pillar, Betäubungsmittelgesetz, Federal Council, Organization, Growth, Partnership, Cannabis Act, Statista, Cannabis, Criminal law, Applied science, Weßling, THC, Advertising, Vocational university, Drug

Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market

Key Points:

Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market
The issuer is solely responsible for the content of this announcement.
Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of April 1, 2024, positive growth opportunities in Europe's largest consumer market
Cannovum Cannabis AG (stock exchanges Frankfurt/Xetra, Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A37FUP2) welcomes the legalization of cannabis in Germany confirmed today by the Federal Council.
This will provide new impetus for a billion-euro market in Europe's largest economy in the coming years.
Cannovum Cannabis AG plans to generate significant sales through offers for existing and emerging cannabis clubs.

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Retrieved on:

Friday, March 22, 2024

Alternative Medicine, Cannabis, Health, Other Health, Natural Resources, General Health, Pharmaceutical, Narcotic, Federal republic, Cannabis Act, Patient, Drug

On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.

Key Points:

On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.
While the Cannabis Act deals with all types of cannabis, it is poised to have a uniquely significant impact on the medical cannabis sector.
This sets the stage for expected significant expansion of the medical cannabis market in Germany.
As a leader in pharmaceutical Cannabis, we are closely watching these developments including the potential rescheduling of Cannabis in the United States, and plan to advance our global footprint, expecting to launch our products in Germany in the coming months.

Curaleaf International Comments As German Federal Cannabis Law Passes Without Delay

Retrieved on:

Friday, March 22, 2024

Today, it has been announced that the German Federal Government's cannabis law, also known as Pillar 1, has successfully progressed without delay.

Key Points:

Today, it has been announced that the German Federal Government's cannabis law, also known as Pillar 1, has successfully progressed without delay.
Juan Martinez, Head of Curaleaf International, a leading cannabis company in Europe, commented:
"The successful passage of the Cannabis Act represents a significant milestone in our journey towards destigmatisation and decriminalisation of cannabis for both patients and consumers.
As a company deeply invested in the European cannabis landscape, we are excited about the opportunities this legislation brings.
Our full seed-to-sale process allows us first mover advantage to meet the anticipated demand from a thriving, regulated, and safe cannabis industry.

Cannabis Act legislative review Expert Panel welcomes the tabling of its final report

Retrieved on:

Thursday, March 21, 2024

Psychosis, Health, Department of Finance Canada, First Nations, Organization, Schizophrenia, Cannabis Act, Act, Pharmacy, Public, Research, Health Canada, Parliament, Cannabis, Government, Drug

OTTAWA, ON, March 21, 2024 /CNW/ - Today, the independent Expert Panel conducting the review of the Cannabis Act welcomed the tabling of its final report in both houses of Parliament.

Key Points:

OTTAWA, ON, March 21, 2024 /CNW/ - Today, the independent Expert Panel conducting the review of the Cannabis Act welcomed the tabling of its final report in both houses of Parliament.
The report, a legislative requirement under the Act, reviews progress toward meeting the Act's objectives and recommends changes to the Act and its supporting regulations and policies.
"The Cannabis Act is a dramatic departure from prohibition, which had been the approach to controlling cannabis for the past century.
The Expert Panel appreciates the opportunity to have undertaken this critical review of the cannabis framework in Canada.

Government of Canada Tables Final Report of the Legislative Review of the Cannabis Act

Retrieved on:

Thursday, March 21, 2024

OTTAWA, ON, March 21, 2024 /CNW/ - In 2018, the Government of Canada introduced the Cannabis Act , which put into place a legal framework that takes a comprehensive public health approach to cannabis.

Key Points:

OTTAWA, ON, March 21, 2024 /CNW/ - In 2018, the Government of Canada introduced the Cannabis Act , which put into place a legal framework that takes a comprehensive public health approach to cannabis.
In accordance with the Act, the Honourable Mark Holland, Minister of Health and the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health released the final report of the Legislative Review of the Cannabis Act.
This final report is the result of the extensive work conducted by the independent Expert Panel, chaired by Morris Rosenberg, that led the review over the last 18 months.
"I would like to thank Chair Rosenberg and the members of the Expert Panel for their enormous effort and dedication in leading the first-ever Legislative Review of the Cannabis Act.

EQS-News: Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, historic opportunity for the economy, billion-euro potential for sales and growth

Retrieved on:

Wednesday, March 13, 2024

Growth, Sale, Applied science, Bundestag, Weßling, Cannabis, Cannabis Act, Drug

Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, historic opportunity for the economy, billion-euro potential for sales and growth

Key Points:

Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, historic opportunity for the economy, billion-euro potential for sales and growth
The issuer is solely responsible for the content of this announcement.
Cannovum Cannabis AG (stock exchanges Frankfurt/Xetra, Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A37FUP2) informs: In a historic decision, the German Bundestag today passed the Cannabis Act.
This will allow the consumption of cannabis in Germany and paves the way for Cannovum Cannabis AG to enter a new growth area.
Great entrepreneurial opportunity: The growth and sales potential of legalization for Cannovum Cannabis AG is enormous.

EQS-News: Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance. Exclusive partnership with some of the largest agricultural companies in Germany

Retrieved on:

Wednesday, March 13, 2024

Vocational university, Growth, Federation, Applied science, Safety, Weßling, Cannabis, Bundestag, Agriculture, Movement, Cannabis Act, Partner, Partnership, Drug

Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.

Key Points:

Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.
With the upcoming cannabis clubs, Cannovum Cannabis AG intends to generate significant revenues and create significant added value for shareholders and society.
Exclusive cultivation areas and services are already available for more than 500 cannabis clubs.

EQS-News: Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance. Exclusive partnership with some of the largest agricultural companies in Germany.

Retrieved on:

Wednesday, March 13, 2024

Vocational university, Growth, Federation, Applied science, Safety, Weßling, Cannabis, Bundestag, Agriculture, Movement, Cannabis Act, Partner, Partnership, Drug

Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.

Key Points:

Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in the cultivation alliance.
With the upcoming cannabis clubs, Cannovum Cannabis AG intends to generate significant revenues and create significant added value for shareholders and society.
Exclusive cultivation areas and services are already available for more than 500 cannabis clubs.

Village Farms International Enthusiastically Supports Standing Committee’s Recommendations for New Cannabis Excise Duty Model

Retrieved on:

Thursday, February 29, 2024

CRA, Collection, Committee, Commons, Federal budget, Committee on Finance, Revenue, Income tax, House, Legislation, Parliament, Cannabis Act, Cannabis

VANCOUVER, British Columbia and ORLANDO, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms”) (NASDAQ: VFF) enthusiastically supports recommendations on changes to the current Cannabis Excise Duty model released this week by the Canadian House of Commons Standing Committee on Finance.

Key Points:

VANCOUVER, British Columbia and ORLANDO, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms”) (NASDAQ: VFF) enthusiastically supports recommendations on changes to the current Cannabis Excise Duty model released this week by the Canadian House of Commons Standing Committee on Finance.
Those recommendations include adjustment to the excise duty formula for cannabis so that it is limited to a 10% ad valorem (proportionate to value) rate.
When the Cannabis Excise Duty model was first adopted, it envisioned a retail selling price of cannabis much higher ($10-plus per gram) than is currently prevalent in today’s market, such that the $1 per gram duty would have effectively been aligned to a 10% ad valorem tax rate.
Related to excise duty payments, Village Farms also notes recent reports with respect to the Canadian Revenue Agency’s (CRA) collection enforcement of the growing past due excise tax balances.

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Retrieved on:

Friday, February 23, 2024

Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.

Key Points:

Germany is expected to pass the Cannabis Act today (Friday), heralding a transformative era for the medical cannabis industry.
The passage of the Cannabis Act represents a pivotal shift, primarily by making it substantially easier and more cost-effective for doctors to prescribe medical cannabis.
The Act's facilitation of the prescription process is anticipated to lead to a surge in demand for medical cannabis.
Looking ahead, Germany's Cannabis Act marks a significant milestone for the medical cannabis industry, promising to increase demand, expand the patient base, and reduce prices through heightened competition.